Understanding and addressing privacy and confidentiality concerns associated with the provision of mobile HIV care: a qualitative study
- PMID: 33938335
- PMCID: PMC8563507
- DOI: 10.1080/09540121.2021.1921104
Understanding and addressing privacy and confidentiality concerns associated with the provision of mobile HIV care: a qualitative study
Abstract
Less than half the people with HIV (PLWH) in the United States (US) are retained in HIV care, underscoring the importance of novel reengagement and retention strategies. Mobile HIV clinics (MHCs) are one such strategy, but privacy and confidentiality concerns have limited their use. As part of a larger mixed-methods study in Atlanta, Georgia, from June 2019- July 2020, we conducted 41 qualitative interviews with key stakeholders to explore confidentiality, privacy and stigma concerns and strategies to address them. Interviews were recorded, transcribed and coded thematically. Four key themes emerged: 1) the need to understand MHC acceptance in the context of high HIV stigma in the South, 2) the multidimensionality of confidentiality and stigma concerns (e.g., related to exterior labeling, layout, location attracting unwanted attention), 3) the counter perspective: potential for MHCs to positively reframe HIV and reduce stigma, and 4) strategies to overcome stigma and confidentiality concerns, including co-delivery of non-HIV services, unidirectional flow, and non-HIV exterior labeling. In furthering understanding of the breadth of privacy and confidentiality concerns associated with an MHC and strategies for addressing them, this exploratory study lays a critical foundation for the development of an MHC to reengage and retain PLWH in the US.
Keywords: HIV; confidentiality; mobile clinics; privacy; stigma.
Conflict of interest statement
Disclosure statement
No potential conflict of interest was reported by the authors.
References
-
- Altice FL, D. BR, Hodges J, Friedland GH, Marinovich A, Mezger JA, Hodges J, Springer SA (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clinical Infectious Disease, 38, S376–387. 10.1086/421400 - DOI - PubMed
-
- CDC. (7/1/20). Basic Statistics Retrieved 08/01/20 rom https://www.cdc.gov/hiv/basics/statistics.html
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials